Clinical Trial Update: Phase 1 Study for Safety and Tolerability of HL036 [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and tolerability of HL036 for dry eye has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• HL036 (HL036)

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Dry Eye | Phase 1 | Status: COMPLETED